Medworxx Solutions Inc.

Medworxx Solutions Inc.

March 17, 2008 08:30 ET

Medworxx Appoints IRonside Investor Relations Inc. as Investor Relations and Financial PR Firm

TORONTO, ONTARIO--(Marketwire - March 17, 2008) - Medworxx Solutions Inc. ("Medworxx") (TSX VENTURE:MWX), a Canadian leader in knowledge management systems for hospitals, today announced that it has appointed IRonside Investor Relations Inc. ("IRonsideIR"), an independent Toronto-based corporate communications firm, to provide it with investor relations and financial public relations services.

IRonsideIR's investor relations team will implement a strategic outreach program to increase awareness of Medworxx's healthcare-focused technology platform, using IRonsideIR's proprietary database of portfolio managers, analysts, and investors. Medworxx will pay approximately $3,000 per month and issue to IronsideIR 150,000 options, each option entitling the holder to acquire one Class A Common Share of Medworxx at an exercise price of $0.19 per share for a term of 12 months. One quarter of the options so granted will vest every three months following the date of being granted. The term of the appointment is for four months, and if the term is renewed, additional options may be granted at that time.

"IRonsideIR is excited to be working with Medworxx," said Robin Sundstrom, President of IRonside Investor Relations Inc. "Their technology platform and their targeted approach to the healthcare industry make them uniquely appealing."

"Medworxx makes a strategic platform that hospitals use to communicate, aggregate, and analyze knowledge. Our most recent addition to this platform, the Emergency Readiness System (ERS), is at the beginning of its sales ramp," said Dan Matlow, President & CEO, Medworxx. "We are looking forward to working with IRonsideIR to build investor awareness of not only our platform but our company and its potential."

About IRonsideIR:

IRonsideIR is a full-service communications firm operating from an investor relations perspective. IRonsideIR is focused on two things: raising the profiles of its corporate clients, and providing a solid return on investment.

About Medworxx:

Medworxx, the makers of strategic software platforms that hospitals use to communicate, aggregate, and analyze knowledge, has been capturing the power of hospital knowledge since 2004. Medworxx' products are used by more than 200,000 users at over 150 hospitals across North America. Headquartered in Toronto, Ontario, Medworxx trades on the Toronto Venture Exchange under the symbol MWX.

Medworxx: our market is healthcare, our vertical is knowledge.

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements. Often, but not always, forward-looking statements can be identified by the use of words such as "plans", "expects" or "does not expect", "is expected", "estimates", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. Forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Medworxx to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, such as costs of sales, general economic conditions, the success of marketing and competition from competing suppliers and businesses. Actual results and developments are likely to differ, and may differ materially, from those expressed or implied by the forward-looking statements contained in this press release. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements.

The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this release.

Contact Information